Extracellular matrix regulates morphogenesis and function of ciliated sensory organs in Caenorhabditis elegans [PDF]
, 2018 Deanna M. De Vore +4 more
openalex +1 more source
Investigation of The effect of Phycocyanin Extracted From Spirulina platensis and Persimmon Powder on Physicochemical and Sensory Characteristics of Yogurt [PDF]
, 2021 Mona Sangian +3 more
openalex +1 more source
Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation.
Trends in immunology, 2017 Felipe A. Pinho-Ribeiro +2 more
semanticscholar +1 more source
Restoration of sensory information via bionic hands
Nature Biomedical Engineering, 2020 S. Bensmaia, D. Tyler, S. Micera
semanticscholar +1 more source
Molecular Oncology, EarlyView.CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Association between sensory processing and dental fear among female undergraduates in Japan
, 2019 Mika Ogawa +5 more
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Differential sensory block during labour epidural analgesia: a prospective observational study to investigate the relationship of lower and upper sensory block levels to cold, pinprick, and light touch [PDF]
Julia F. Casellato +5 more
openalex +1 more source
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Molecular Oncology, EarlyView.HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source